Verastem EBITDA per Share 2011-2026 | VSTM

Annual EBITDA per Share Verastem

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-2.45	-3.22	-4.17	-4.51	-4.21	-0.32	-1.75	-1.45	-1.75	-0.982	-1.6	-2.06	-1.82	-1.71	-10.5

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-0.32	-10.5	-2.83

Quarterly EBITDA per Share Verastem

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-0.82	-	-	-	-1.05	-	-	-	-1.15	-	-1.07	-1.37	-0.09	-	-0.08	-0.09	-0.08	-0.1	0.09	-0.13	-0.24	-0.44	-0.35	-0.52	-0.47	-0.46	-0.28	-0.28	-0.41	-0.43	-0.6	-0.36	-0.35	-0.32	-0.2	-0.23	-0.22	-0.32	-0.41	-0.41	-0.45	-0.53	-0.51	-0.5	-0.51	-0.45	-0.43	-0.49	-0.44	-0.39	-0.51	-0.34	-0.47	-4.01	-2.94	-2.02	-1.05

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
0.09	-4.01	-0.598

EBITDA per Share of other stocks in the Biotechnology industry

Issuer	EBITDA per Share	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-15.2	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	-188	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	-6.85	-	-	$ 86.2 M	USA
Amgen AMGN	26.5	$ 349.36	2.75 %	$ 188 B	USA
AlloVir ALVR	-3.02	-	4.14 %	$ 49.1 M	USA
Amneal Pharmaceuticals AMRX	1.44	$ 12.67	2.82 %	$ 3.97 B	USA
Applied Molecular Transport AMTI	-3.2	-	-	$ 10.1 M	USA
Applied Therapeutics APLT	-0.77	-	-	$ 8.42 M	USA
argenx SE ARGX	-6.83	$ 784.45	2.48 %	$ 25 B	Niderland
I-Mab IMAB	0.08	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	6.75	-	-	$ 40.3 B	USA
Genfit SA GNFT	-2.24	-	2.54 %	$ 160 B	France
Arcutis Biotherapeutics ARQT	-0.09	$ 24.45	5.07 %	$ 3.11 B	USA
Biophytis SA BPTS	-0.23	-	-13.47 %	$ 169 M	France
AVROBIO AVRO	0.24	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	-2.42	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	0.74	-	-	$ 96.9 B	Britain
Midatech Pharma plc MTP	-0.09	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.22	-	-1.52 %	$ 24.7 M	USA
Autolus Therapeutics plc AUTL	-0.99	$ 1.47	8.17 %	$ 391 M	Britain
BeiGene, Ltd. BGNE	0.42	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	-1.68	$ 3.83	1.86 %	$ 9.21 B	Australia
BioNTech SE BNTX	62.6	$ 91.3	1.87 %	$ 27.2 B	Germany
CymaBay Therapeutics CBAY	-0.95	-	-	$ 3.45 B	USA
Advaxis ADXS	-5.96	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	-0.39	$ 2.72	5.84 %	$ 17.1 M	USA
Burford Capital Limited BUR	1.11	$ 4.59	0.88 %	$ 742 M	Britain
Avid Bioservices CDMO	-0.12	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	-27.7	-	-	$ 1.41 B	USA
Институт стволовых клеток человека ISKJ	-2.69	-	-	-	Russia
Cabaletta Bio CABA	-1.7	$ 3.07	-	$ 308 M	USA
Can-Fite BioPharma Ltd. CANF	-0.01	$ 3.08	1.65 %	$ 6.7 B	Israel
Checkpoint Therapeutics CKPT	-1.42	-	-	$ 169 M	USA
Cerus Corporation CERS	-0.04	$ 1.93	4.89 %	$ 368 M	USA
Aeterna Zentaris AEZS	-0.08	-	5.93 %	$ 314 M	Canada
Checkmate Pharmaceuticals CMPI	-2.84	-	-	$ 231 M	USA
AgeX Therapeutics AGE	-2.35	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	-2.21	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	-6.7	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-0.36	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	-0.68	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	-3.89	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	0.01	-	-45.71 %	$ 1.2 M	Canada
Cyclacel Pharmaceuticals CYCCP	-3.85	-	-4.36 %	$ 27 M	USA
Cellectar Biosciences CLRB	-8.73	$ 2.82	2.55 %	$ 7.36 M	USA
Deciphera Pharmaceuticals DCPH	-2.46	-	-	$ 2.18 B	USA
Akero Therapeutics AKRO	-4.25	-	-	$ 3.67 B	USA
Dynavax Technologies Corporation DVAX	-0.25	-	-	$ 2.02 B	USA
CureVac N.V. CVAC	-2.22	-	-	$ 867 M	Germany
Cyclerion Therapeutics CYCN	-1.44	$ 3.47	-0.29 %	$ 8.74 M	USA